Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
For patients with locally advanced ESCC, NCRI showed a significantly higher pCR rate than conventional NCRT, without increased operative risk. NCRI followed by surgery exhibited a superior RFS compared to NCRT followed by surgery. Prospective studies are needed in the future.
Authors
- Xiankai Chen (ORCID: https://orcid.org/0000-0003-4228-9562)
- Wenyang Liu (ORCID: https://orcid.org/0000-0002-6978-7169)
- Yin Li (ORCID: https://orcid.org/0000-0001-7676-2659)
- Zongmei Zhou (ORCID: https://orcid.org/0000-0002-8336-2319)
- Qinfu Feng
- Xin Wang
- Nan Bi
- Lei Deng (ORCID: https://orcid.org/0000-0001-5919-5074)
- Wenqing Wang (ORCID: https://orcid.org/0000-0002-6710-4045)
- Tao Zhang (ORCID: https://orcid.org/0000-0003-4861-0679)
- Jianyang Wang (ORCID: https://orcid.org/0000-0002-1430-4158)
- Jianjun Qin (ORCID: https://orcid.org/0000-0002-2008-6193)
- Cong Li (ORCID: https://orcid.org/0009-0000-9658-5717)
- Ruixiang Zhang (ORCID: https://orcid.org/0009-0009-3728-5170)
- Jima Lv
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1111/1759-7714.70054
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00